Procter & Gamble Health (BOM:500126) Long-Term Capital Lease Obligation : ₹0 Mil (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Procter & Gamble Health Long-Term Capital Lease Obligation?

Procter & Gamble Health's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0 Mil.

Procter & Gamble Health's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (₹0 Mil) to Dec. 2023 (₹80 Mil) but then declined from Dec. 2023 (₹80 Mil) to Mar. 2024 (₹0 Mil).

Procter & Gamble Health's annual Long-Term Capital Lease Obligation declined from Jun. 2021 (₹29 Mil) to Jun. 2022 (₹0 Mil) but then increased from Jun. 2022 (₹0 Mil) to Jun. 2023 (₹89 Mil).

Procter & Gamble Health Long-Term Capital Lease Obligation Historical Data

The historical data trend for Procter & Gamble Health's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procter & Gamble Health Long-Term Capital Lease Obligation Chart

Procter & Gamble Health Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Jun21

Jun22

Jun23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

28.60

88.80

Procter & Gamble Health Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	88.80	-	80.30	-

Procter & Gamble Health (BOM:500126) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Procter & Gamble Health Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Procter & Gamble Health's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Procter & Gamble Health (BOM:500126) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procter & Gamble Health Ltd (BOM:500126) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

PGHL:India

Address

Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Chakala, Andheri East, Mumbai, MH, IND, 400099

Website

https://www.pghealthindia.com

Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company's distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.

Procter & Gamble Health (BOM:500126) Headlines

No Headlines